Literature DB >> 19575011

CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing.

Judith Pirngruber1, Andrei Shchebet, Lisa Schreiber, Efrat Shema, Neri Minsky, Rob D Chapman, Dirk Eick, Yael Aylon, Moshe Oren, Steven A Johnsen.   

Abstract

Post-translational histone modifications have essential roles in controlling nuclear processes; however, the specific mechanisms regulating these modifications and their combinatorial activities remain elusive. Cyclin-dependent kinase 9 (CDK9) regulates gene expression by phosphorylating transcriptional regulatory proteins, including the RNA polymerase II carboxy-terminal domain. Here, we show that CDK9 activity is essential for maintaining global and gene-associated levels of histone H2B monoubiquitination (H2Bub1). Furthermore, CDK9 activity and H2Bub1 help to maintain correct replication-dependent histone messenger RNA (mRNA) 3'-end processing. CDK9 knockdown consistently resulted in inefficient recognition of the correct mRNA 3'-end cleavage site and led to increased read-through of RNA polymerase II to an alternative downstream polyadenylation signal. Thus, CDK9 acts to integrate phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575011      PMCID: PMC2726677          DOI: 10.1038/embor.2009.108

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  23 in total

1.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.

Authors:  Hongjuan Zhao; Anita Langerød; Youngran Ji; Kent W Nowels; Jahn M Nesland; Rob Tibshirani; Ida K Bukholm; Rolf Kåresen; David Botstein; Anne-Lise Børresen-Dale; Stefanie S Jeffrey
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

2.  The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions.

Authors:  Jaehoon Kim; Sandra B Hake; Robert G Roeder
Journal:  Mol Cell       Date:  2005-12-09       Impact factor: 17.970

3.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

4.  Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation.

Authors:  Bing Zhu; Yong Zheng; Anh-Dung Pham; Subhrangsu S Mandal; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

5.  Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription.

Authors:  J R Davie; L C Murphy
Journal:  Biochemistry       Date:  1990-05-22       Impact factor: 3.162

6.  Polyadenylation and U7 snRNP-mediated cleavage: alternative modes of RNA 3' processing in two avian histone H1 genes.

Authors:  A L Kirsh; M Groudine; P B Challoner
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

7.  Histone H2B ubiquitylation is associated with elongating RNA polymerase II.

Authors:  Tiaojiang Xiao; Cheng-Fu Kao; Nevan J Krogan; Zu-Wen Sun; Jack F Greenblatt; Mary Ann Osley; Brian D Strahl
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

8.  Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7.

Authors:  Rob D Chapman; Martin Heidemann; Thomas K Albert; Reinhard Mailhammer; Andrew Flatley; Michael Meisterernst; Elisabeth Kremmer; Dirk Eick
Journal:  Science       Date:  2007-12-14       Impact factor: 47.728

9.  Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.

Authors:  Steven A Johnsen; Cenap Güngör; Tanja Prenzel; Sabine Riethdorf; Lutz Riethdorf; Naoko Taniguchi-Ishigaki; Thomas Rau; Baris Tursun; J David Furlow; Guido Sauter; Martin Scheffner; Klaus Pantel; Frank Gannon; Ingolf Bach
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Gene expression signature of estrogen receptor alpha status in breast cancer.

Authors:  Martín C Abba; Yuhui Hu; Hongxia Sun; Jeffrey A Drake; Sally Gaddis; Keith Baggerly; Aysegul Sahin; C Marcelo Aldaz
Journal:  BMC Genomics       Date:  2005-03-11       Impact factor: 3.969

View more
  86 in total

Review 1.  The RNA polymerase II CTD "orphan" residues: Emerging insights into the functions of Tyr-1, Thr-4, and Ser-7.

Authors:  Nathan M Yurko; James L Manley
Journal:  Transcription       Date:  2017-10-04

2.  Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation.

Authors:  Vasupradha Vethantham; Yan Yang; Christopher Bowman; Patrik Asp; Jeong-Heon Lee; David G Skalnik; Brian D Dynlacht
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

3.  Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.

Authors:  Shaoyong Chen; Sarah Gulla; Changmeng Cai; Steven P Balk
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

4.  Total RNA-seq to identify pharmacological effects on specific stages of mRNA synthesis.

Authors:  Sarah A Boswell; Andrew Snavely; Heather M Landry; L Stirling Churchman; Jesse M Gray; Michael Springer
Journal:  Nat Chem Biol       Date:  2017-03-06       Impact factor: 15.040

Review 5.  Pause, play, repeat: CDKs push RNAP II's buttons.

Authors:  Miriam Sansó; Robert P Fisher
Journal:  Transcription       Date:  2013-06-11

6.  HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

Authors:  Bijan Sobhian; Nadine Laguette; Ahmad Yatim; Mirai Nakamura; Yves Levy; Rosemary Kiernan; Monsef Benkirane
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

7.  Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Authors:  Olivier Bensaude
Journal:  Transcription       Date:  2011-05

Review 8.  Birth and Death of Histone mRNAs.

Authors:  William F Marzluff; Kaitlin P Koreski
Journal:  Trends Genet       Date:  2017-08-31       Impact factor: 11.639

9.  Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma.

Authors:  Xinwei Yun; Keqiang Zhang; Jinhui Wang; Rajendra P Pangeni; Lu Yang; Melissa Bonner; Jun Wu; Jami Wang; Isaac K Nardi; Ming Gao; Dan J Raz
Journal:  Mol Cancer Res       Date:  2018-05-02       Impact factor: 5.852

10.  The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination.

Authors:  Lindsey Long; Joseph P Thelen; Melonnie Furgason; Mahmood Haj-Yahya; Ashraf Brik; Dongmei Cheng; Junmin Peng; Tingting Yao
Journal:  J Biol Chem       Date:  2014-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.